- Papers in database
- 11
- Primary author
- 1 paper
- Years active
- 2018 – 2026
- Health outcomes studied
- 1
Health Outcomes Studied
Papers (11)
- 2026Yeast species resource exploration and application in cell factories.10.1016/j.synbio.2025.12.007
- 2026Primary authorThe efficacy and safety of Femoston combined with Baoqing granules for kidney Yin deficiency in perimenopausal women: a randomized, double-blind, placebo-controlled trial.10.3389/fendo.2026.1791905
- 2025Research progress on pharmacological effects against liver and eye diseases of flavonoids present in Chrysanthum indicum L., Chrysanthemum morifolium Ramat., Buddleja officinalis Maxim. and Sophora japonica L.10.1016/j.jep.2024.119094
- 2025Efficacy and safety of Qishen granule for treating heart failure with preserved ejection fraction: a study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.10.1186/s12906-025-05029-z
- 2024Clinical efficacy of probiotics in the treatment of alcoholic liver disease: a systematic review and meta-analysis.10.3389/fcimb.2024.1358063
- 2024Phenolic acids from medicinal and edible homologous plants: a potential anti-inflammatory agent for inflammatory diseases.10.3389/fimmu.2024.1345002
- 2021Endophytes: the novel sources for plant terpenoid biosynthesis.10.1007/s00253-021-11350-7
- 20202'-Fucosyllactose promotes Bifidobacterium bifidum DNG6 adhesion to Caco-2 cells.10.3168/jds.2020-18773
- 2019Modulatory effect of Lactobacillus acidophilus KLDS 1.0738 on intestinal short‐chain fatty acids metabolism and GPR41/43 expression in β‐lactoglobulin–sensitized mice10.1111/1348-0421.12723
- 2019Lactobacillus plantarum KLDS1.0318 Ameliorates Impaired Intestinal Immunity and Metabolic Disorders in Cyclophosphamide-Treated Mice10.3389/fmicb.2019.00731
- 2018A hindsight reflection on the clinical studies of poly(l-glutamic acid)-paclitaxel.10.1002/wnan.1497